USPTO serial 79277939
INCYTON
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 29, 2020
- Examiner
- BRACEY, KAREN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with INCYTON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Walter Hill Levie III
Walter Hill Levie III Meunier Carlin & Curfman LLC999 Peachtree Street NESuite 1300Atlanta, GA 30309Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific apparatus and instruments, namely, physiometabolic cell analyzer and screener, measuring instruments, namely, scientific instrumentation for measuring physiological parameters of cells; photoelectric sensors; optical readers; laboratory robots; diagnostic apparatus, not for medical purposes, namely, for the detection of pathogens for laboratory or research use; downloadable bioinformatics software for analyzing experimental and cellular physiological data; biochip sensors; biochips for research or scientific purposes; apparatus and instruments for microscopy, namely, microscopes; laboratory apparatus and instruments, namely, apparatus for manipulating and monitoring living cells; laboratory incubators; incubators for laboratory use; bioreactors for cell culture; disposable plastic bioreactors for cell culture; biological microscopes; microscopes; scientific apparatus, namely, microscopic imaging system not for medical use; apparatus for recording images; bioreactors for laboratory use; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids | ACTIVE | — |
| 042 | Scientific investigations for medical purposes; scientific research for medical purposes; scientific research relating to cosmetics; scientific research relating to biology; scientific research in the field of pharmacy; preparation of biological samples for testing and analysis in research laboratories; preparation of biological samples for analysis in research laboratories; preparation of biological samples for research purposes; rental of software for computers; rental of laboratory apparatus and instruments; rental of computer software; rental of computer programs; medical research; laboratory research services relating to pharmaceuticals; laboratory research in the field of chemistry; laboratory research in the field of cosmetics; cosmetic research; research and development services in the field of microorganisms and cells; research and development services in the field of biotechnology; research and development services for the pharmaceutical industry; research in the field of pharmaceuticals; research in the field of biotechnology; research and development of vaccines and medicines; design and development of testing and analysis methods; biotechnological research; scientific biological laboratory services; biological research and analysis; biological research services; biological research; biochemical research and analysis; biochemical research services; consultancy in the field of biology; consultancy in the field of biochemistry; bacteriological research and analysis; bacteriological research; laboratory analysis in the field of molecular biology; scientific research for medical purposes in the field of cancerous diseases; research in the fields of chemistry and biology; scientific research in the field of bacteriology; technical writing, namely, preparation of reports relating to technological research; rental of computer software and programs; pharmaceutical research services; pharmaceutical research and development services; medical research laboratory services; medical research services; laboratory research in the field of pharmaceuticals; research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibodies; biological research laboratory services; research and development in the field of biochemistry; research and development in the field of biotechnology; research and development in the field of microorganisms and cells; research and development of vaccines; research and development services in the field of cytology; research and development services in the field of immunology; research and development services in the field of gene expression systems; research and development services in the field of chemistry; research and development services in the field of antibody technology; research in the field of chemistry; biological and chemical research; biological and chemical research services; biotechnological research; scientific research for medical purposes in the area of cancerous diseases; technical writing, namely, preparation of reports relating to scientific research; providing information relating to scientific research in the fields of biochemistry and biotechnology; laboratory testing of cell culture cell lines under influence of substances; analytical research laboratory services; laboratory research and analysis in the fields of toxicology and oncology; biological research and analysis services; medical and pharmacological research services; biochemical analysis; biochemical research; provision of scientific information and data relating to medical and veterinary research and development; scientific advisory services relating to gene therapy research; consultancy relating to laboratory testing; consultancy in the field of pharmaceutical research; consultancy in the field of pharmacology; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutic pharmaceutical preparations; consultancy relating to research in the field of pharmacogenetics; consultancy relating to pharmaceutical research and development; consultancy in the field of biotechnology; consultancy in the field of scientific research | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by INCYTON GmbH
- Other trademarks owned by INCYTON GmbH
- Other trademarks owned by INCYTON GmbH
- Other trademarks owned by Incyton Biotech GmbH
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named INCYTON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 29, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 11, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 6, 2025 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 24, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 6, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 6, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 29, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 29, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 18, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 13, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 13, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 30, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 30, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 23, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 4, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 3, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 2, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 2, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 13, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 13, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 13, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 13, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 19, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 28, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 9, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 9, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 14, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 13, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |